Company intelligence / Profile preview

Hangzhou Meiya Medical Nutritional Technology

Hangzhou City, Zhejiang Province, Chinameiyapharm.net ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Hangzhou Meiya Pharmaceutical specializes in the production of nucleotides, nucleic acids, enzymes, and related biochemical raw materials. The company holds GMP certification for several products such as adenosine 3',5'-cyclic monophosphate and aprotinin. It operates at a commercial scale supplying APIs globally but does not appear to have its own clinical drug development pipeline.

Modalities: Small moleculeProtein
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Hangzhou Meiya Medical Nutritional Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Meiya Medical Nutritional Technology.

Explore the full profile